Impax Laboratories' P2P Acquisition

Impax Laboratories raised a round of funding on October 17, 2017. Investors include Amneal Pharmaceuticals.

Impax Laboratories is a technology-based specialty pharmaceutical company utilizing core competencies in drug delivery and formulation expertise. …

Articles about Impax Laboratories' P2P Acquisition: